Clinical Trial Update: Nasal Protollin in Early Symptomatic Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of nasal Protollin in early symptomatic Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nasal Protollin (Protollin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Alzheimer Disease (AD) | Phase 1 | Status: COMPLETED